Seneca Snakeroot (Polygala senega): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Seneca snakeroot work as an expectorant?

Seneca snakeroot contains saponins, particularly senegin and senegenin, which provide its expectorant action. These compounds irritate the gastric mucosa, stimulating reflex secretion in the respiratory tract. This increases mucus production and reduces viscosity, making phlegm easier to cough up. The methyl salicylate content also contributes mild anti-inflammatory effects. Evidence level: C.

Does Seneca snakeroot interact with any medications?

Seneca snakeroot may interact with medications affecting the gastrointestinal tract due to its irritant saponins. It should be avoided with anticoagulants, as saponins may affect blood clotting. The methyl salicylate content could potentially interact with blood thinners like warfarin. Those taking medications for kidney conditions should avoid this herb entirely. Always consult a healthcare provider before combining with prescription medications. Evidence level: Traditional/C.

What is the recommended dosage for Seneca snakeroot?

The traditional adult dosage for Seneca snakeroot is 1-2 grams of dried root prepared as a tea, taken three times daily. Alternatively, 1.5-3 milliliters of tincture can be taken three times daily. Doses exceeding these recommendations may cause nausea, vomiting, and gastric irritation due to the saponin content. Start with lower doses to assess tolerance. Evidence level: Traditional.

Is Seneca snakeroot safe during pregnancy?

Seneca snakeroot is considered unsafe during pregnancy and should be strictly avoided. The saponins can irritate the uterus and potentially stimulate uterine contractions, posing a risk of miscarriage. Additionally, the herb's emetic properties at higher doses could cause dehydration and electrolyte imbalances harmful during pregnancy. Breastfeeding women should also avoid this herb due to insufficient safety data. Evidence level: Traditional/C.

What is Seneca snakeroot used for traditionally?

Seneca snakeroot has been used traditionally by the Seneca Nation as a treatment for rattlesnake bites, which gave the plant its common name. Native American medicine also employed it as an expectorant for respiratory conditions. European pharmacopoeia later adopted it for treating bronchitis and rheumatic conditions. Modern herbal use focuses primarily on its expectorant properties for clearing chest congestion. Evidence level: Traditional/C.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Polygala senega is a medicinal herb used traditionally for lung diseases and studied for its anticancer, hypoglycemic, and immunomodulatory properties [PMID: 20869020, 8923811, 18066120].

Background

Polygala senega (Seneca Snakeroot) is a plant indigenous to the Canadian prairies [PMID: 18066120, 10660256].

Traditional uses

It is extensively used in traditional systems of medicine against various lung diseases, including cancer [PMID: 20869020].

Active compounds

The root contains triterpenoid saponins (including senegins II-IV and senegasaponins a-c), tenuifolin (presenegenin 3-β-d-glucopyranoside), and various oligosaccharide multi-esters known as senegoses [PMID: 34730980, 21042868, 8370112, 8004714, 8118905].

Mechanism of action

Anticancer activity in lung cancer cells (A549) is associated with decreased expression of survivin and PCNA mRNA, and increased expression of caspase-3 and p53 mRNAs [PMID: 20953431]. Senegin III inhibits VEGF-induced tubular formation of HUVECs and bFGF-induced neovascularization [PMID: 21042868]. Immunological activity involves increasing IgG2a subclass antibody responses and increasing IL-2 and IFN-gamma levels in spleen cell cultures [PMID: 18066120, 10660256].

Clinical evidence

Evidence DLung Cancer (In vitro/In vivo)

Ethanolic root extract induced apoptosis in A549 lung cancer cells [PMID: 20953431, 20869020] and showed anticancer potential against benzo[a]pyrene-induced lung cancer in mice [PMID: 21419086].

Evidence DHyperglycemia/Diabetes (Animal models)

Senegin-II and senegasaponins significantly reduced blood glucose levels in normal and non-insulin dependent diabetic (KK-Ay) mice [PMID: 8923811, 9214731, 8535417, 8582013, 8706138].

Evidence DInflammation (In vitro)

Extract fractions significantly inhibited LPS-induced inflammatory cytokines IL-1beta, IL-6, and TNFalpha in murine macrophage RAW 164.7 cells [PMID: 19577624].

Evidence DImmune Response (Animal models)

Saponins from the root acted as adjuvants, increasing specific antibody responses and IL-2 levels in mice [PMID: 18066120, 10660256].

Evidence DAlcohol Absorption (Animal models)

Senegasaponins and senegins exhibited inhibitory effects on ethanol absorption in rats [PMID: 7728939, 8582013, 8706138].

Safety & adverse effects

In mouse models, P. senega saponins were found to be less toxic (via haemolytic activity assay and lethality) than Quillaja saponaria saponins [PMID: 18066120, 10660256].

Evidence summary

The current evidence is primarily based on in vitro cell lines and in vivo animal models (Level D), with no human clinical trials provided in the abstracts.

PubMed sources

1.PMID: 20953431 (2011) — Anticancer Potentials of Root Extract of Polygala senega and Its PLGA Nanoparticles-Encapsulated Form. · Evidence-based complementary and alternative medicine : eCAM
2.PMID: 34730980 (2021) — Preparation of Tenuifolin from Polygala senega L. Root Using a Hydrolytic Continuous Flow System under High-Temperature, High-Pressure Conditions. · The Journal of organic chemistry
3.PMID: 18066120 (2007) — Adjuvant activities of saponins from the root of Polygala senega L. · Canadian journal of physiology and pharmacology
4.PMID: 21419086 (2011) — Anticancer potentials of root extract of Polygala senega against benzo[a]pyrene-induced lung cancer in mice. · Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
5.PMID: 20869020 (2010) — In vitro and in vivo studies demonstrate anticancer property of root extract of Polygala senega.

Seneca Snakeroot

Sources & Citations

Calculate a safe dose of Seneca Snakeroot